Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("HILSENBECK, Susan")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 82

  • Page / 4
Export

Selection :

  • and

Making Sense of Clinical Trial Data: Is Inverse Probability of Censoring Weighted Analysis the Answer to Crossover Bias?RIMAWI, Mothaffar; HILSENBECK, Susan G.Journal of clinical oncology. 2012, Vol 30, Num 4, pp 453-458, issn 0732-183X, 6 p.Article

Array-based gene expression profiling to study agingHAN, Eun-Soo; HILSENBECK, Susan G.Mechanisms of ageing and development. 2001, Vol 122, Num 10, pp 999-1018, issn 0047-6374Article

Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAILQUN LIU; HILSENBECK, Susan; GAZITT, Yair et al.Blood. 2003, Vol 101, Num 10, pp 4078-4087, issn 0006-4971, 10 p.Article

Sp1 is essential for estrogen receptor α gene transcriptionDEGRAFFENRIED, Linda A; HILSENBECK, Susan G; FUQUA, Suzanne A. W et al.Journal of steroid biochemistry and molecular biology. 2002, Vol 82, Num 1, pp 7-18, issn 0960-0760, 12 p.Article

atxA controls Bacillus anthracis capsule synthesis via acpA and a newly discovered regulator, acpBDRYSDALE, Melissa; BOURGOGNE, Agathe; HILSENBECK, Susan G et al.Journal of bacteriology. 2004, Vol 186, Num 2, pp 307-315, issn 0021-9193, 9 p.Article

Fibroblast Growth Factor Receptor Signaling Dramatically Accelerates Tumorigenesis and Enhances Oncoprotein Translation in the Mouse Mammary Tumor Virus-Wnt-1 Mouse Model of Breast CancerPOND, Adam C; HERSCHKOWITZ, Jason I; LLOYD, Richard E et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 12, pp 4868-4879, issn 0008-5472, 12 p.Article

Gene expression in Barrett's esophagus: Laser capture versus whole tissueEL-SERAG, Hashem B; NURGALIEVA, Zhannat Z; MISTRETTA, Toni-Ann et al.Scandinavian journal of gastroenterology. 2009, Vol 44, Num 7, pp 787-795, issn 0036-5521, 9 p.Article

Mechanisms of tumor regression and resistance to estrogen deprivation and fulvestrant in a model of estrogen receptor- positive, HER-2/neu-positive breast cancerMASSARWEH, Suleiman; OSBORNE, C. Kent; SHOU JIANG et al.Cancer research (Baltimore). 2006, Vol 66, Num 16, pp 8266-8273, issn 0008-5472, 8 p.Article

Primary breast cancer phenotypes associated with propensity for central nervous system metastasesTHAM, Yee-Lu; SEXTON, Krystal; KRAMER, Rita et al.Cancer. 2006, Vol 107, Num 4, pp 696-704, issn 0008-543X, 9 p.Article

Wnt-1 is dominant over neu in specifying mammary tumor expression profilesSHIXIA HUANG; PODSYPANINA, Katrina; YIDONG CHEN et al.Technology in cancer research & treatment (Print). 2006, Vol 5, Num 6, pp 565-571, issn 1533-0346, 7 p.Article

Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan) (AC) response and resistanceCLEATOR, Susan; TSIMELZON, Anna; CHANG, Jenny C et al.Breast cancer research and treatment. 2006, Vol 95, Num 3, pp 229-233, issn 0167-6806, 5 p.Article

Cfos is critical for MCF-7 breast cancer cell growthCHUNHUA LU; QIANG SHEN; DUPRE, Elizabeth et al.Oncogene (Basingstoke). 2005, Vol 24, Num 43, pp 6516-6524, issn 0950-9232, 9 p.Article

The p160 ER co-regulators predict outcome in ER negative breast cancerSPEARS, Melanie; OESTERREICH, Steffi; JACK, Wilma J. L et al.Breast cancer research and treatment. 2012, Vol 131, Num 2, pp 463-472, issn 0167-6806, 10 p.Article

A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancerMASSARWEH, Suleiman; THAM, Yee L; FUQUA, Suzanne et al.Breast cancer research and treatment. 2011, Vol 129, Num 3, pp 819-827, issn 0167-6806, 9 p.Article

Identification of Novel Kinase Targets for the Treatment of Estrogen Receptor―Negative Breast CancerSPEERS, Corey; TSIMELZON, Anna; SEXTON, Krystal et al.Clinical cancer research (Print). 2009, Vol 15, Num 20, pp 6327-6340, issn 1078-0432, 14 p.Article

Effect of epidermal growth factor receptor inhibitor on development of estrogen receptor-negative mammary tumorsCHUNHUA LU; SPEERS, Corey; MOHSIN, Syed K et al.Journal of the National Cancer Institute. 2003, Vol 95, Num 24, pp 1825-1833, issn 0027-8874, 9 p.Article

Genomic approaches to understanding and treating breast cancerFUQUA, Suzanne A. W; CHANG, Jenny C; HILSENBECK, Susan G et al.Breast disease. 2004, Vol 19, pp 35-46, issn 0888-6008, 12 p.Article

Medical complications and outcomes after hip fracture repairLAWRENCE, Valerie A; HILSENBECK, Susan G; NOVECK, Helaine et al.Archives of internal medicine (1960). 2002, Vol 162, Num 18, pp 2053-2057, issn 0003-9926Article

Low SAFB levels are associated with worse outcome in breast cancer patientsHAMMERICH-HILLE, Stephanie; BARDOUT, Valerie J; HILSENBECK, Susan G et al.Breast cancer research and treatment. 2010, Vol 121, Num 2, pp 503-509, issn 0167-6806, 7 p.Article

Hazard rates of recurrence following diagnosis of primary breast cancerJATOI, Ismail; TSIMELZON, Anna; WEISS, Heidi et al.Breast cancer research and treatment. 2005, Vol 89, Num 2, pp 173-178, issn 0167-6806, 6 p.Article

Comparison of ORG1RF and an isogenic fsrB deletion mutant by transcriptional analysis : the Fsr system of Enterococcus faecalis is more than the activator of gelatinase and serine proteaseBOURGOGNE, Agathe; HILSENBECK, Susan G; DUNNY, Gary M et al.Journal of bacteriology. 2006, Vol 188, Num 8, pp 2875-2884, issn 0021-9193, 10 p.Article

Association of Surgery With Improved Survival in Stage IV Breast Cancer PatientsBLANCHARD, D. Kay; SHETTY, Priya B; HILSENBECK, Susan G et al.Annals of surgery. 2008, Vol 247, Num 5, pp 732-738, issn 0003-4932, 7 p.Article

Global effects of virulence gene regulators in a Bacillus anthracis strain with both virulence plasmidsBOURGOGNE, Agathe; DRYSDALE, Melissa; HILSENBECK, Susan G et al.Infection and immunity. 2003, Vol 71, Num 5, pp 2736-2743, issn 0019-9567, 8 p.Article

Pathological features and BRCA1 mutation screening in premenopausal breast cancer patientsCHANG, Jenny; HILSENBECK, Susan G; JEN HWEI SNG et al.Clinical cancer research. 2001, Vol 7, Num 6, pp 1739-1742, issn 1078-0432Article

Is there a role for adjuvant tamoxifen in progesterone receptor-positive breast cancer? An In silica clinical trialHILSENBECK, Susan G; KENT OSBORNE, C.Clinical cancer research. 2006, Vol 12, Num 3, issn 1078-0432, 1049s-1055s, 2Conference Paper

  • Page / 4